Demonstration of synergistic effects of sulfonamides and dihydrofolate reductase/thymidylate synthase inhibitors against Neospora caninum tachyzoites in cultured cells, and characterization of mutants resistant to pyrimethamine

American Journal of Veterinary Research

Volumn 57, Issue 1, 1996, Pages 68-72

  Lindsay, David S ^a   Butler, Jamie M ^a   Rippey, Natasha S ^a   Blagburn, Byron L ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAVERIDINE; METHOTREXATE; ORMETOPRIM; PIRITREXIM; PYRIMETHAMINE; SULFADIAZINE; SULFADIMETHOXINE; SULFADIMIDINE; SULFAMERAZINE; SULFAMETHOXAZOLE; SULFAQUINOXALINE; SULFATHIAZOLE; SULFONAMIDE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ARTICLE; CELL CULTURE; HUMAN; HUMAN CELL; MUTAGENESIS; MUTATION; PARASITE;

ANIMALS; ANTI-INFECTIVE AGENTS; CELL LINE; COCCIDIOSTATS; DRUG RESISTANCE; DRUG SYNERGISM; ENZYME INHIBITORS; FIBROBLASTS; FOLIC ACID ANTAGONISTS; HUMANS; MALE; NEOSPORA; PYRIMETHAMINE; PYRIMIDINES; SKIN; SULFONAMIDES; TETRAHYDROFOLATE DEHYDROGENASE; THYMIDYLATE SYNTHASE; TRIMETHOPRIM;

EID: 0030033225     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Dubey JP, Lindsay DS. Neosporosis. Parasitol Today 1993; 9:452-458
2. Lindsay DS Dubey JP, Cole RA, et al. Neospora-induced abortions in cattle Compend Contin Educ Pract Vet 1993;15:882-889.
3. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992,15:211-222.
4. Long PL. Avian coccidiosis In: Kreier JP, ed. Parasitic protozoa. 2nd ed. Vol 4. San Diego: Academic Press Inc. 1993;1-88.
5. Hay WH, Shell LG, Lindsay DS, et al Diagnosis and treatment of Neospora caninum infection in a dog J Am Vet Med Assoc 1990,197:87-89.
6. McGlennon NJ, Jefferies AR, Casas C. Polyradiculoneuritis and polymyositis due to a Toxoplasma-like protozoan: diagnosis and treatment. J Small Anim Pract 1990,31 102-104
7. Mayhew IG, Smith KC, Dubey JP, et al Treatment of encephalomyeulius due to Neospora caninum in a litter of puppies. J Small Anim Pract 1991,32:609-612.
8. Allegra CJ, Boarman D, Kovacs JA, et al. Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase. J Clin Invest 1990;85:371-379.
9. Pfefferkorn ER, Borotz SE, Nothnagel RF Toxoplasma gondit, characterization of a mutant resistant to sulfonamides. Exp Parasitol 1992,74 261-270.
10. Roos DS Primary structure of the dihydrofolate reductase-thymidylate synthase gene from Toxoplasma gondii. J Biol Chem 1993,9:6269-6280
11. Donald RGK, Roos DS. Stable molecular transformation of Toxoplasma gondii. a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance in malaria. Proc Natl Acad Sci U S A 1993,90:11703-11707.
12. Donald RGK, Roos DS. Homologous recombination and gene replacement at the dihydrofolate reductase-thymidylate synthase locus in Toxoplasma gondii Mol Biochem Parasitol 1994;63: 243-253.
13. Lindsay DS, Dubey JP Evaluation of anti-coccidial drugs' inhibition of Neospora caninum in cell cultures. J Parasitol 1989;75: 990-992.
14. Lindsay DS, Rippey NS, Cole RA, et al. Examination of the activities of 43 chemotherapeutic agents against Neospora caninum tachyzoites in cultured cells. Am J Vet Res 1994;55:976-981
15. Pfefferkorn ER, Pfefferkorn LC. Toxoplasma gondii: isolation and preliminary characterization of temperature-sensitive mutanis. Exp Parasitol 1976;39:365-376.
16. Pfefferkorn ER Characterization of a mutant of Toxoplasma gondii resistant to aphidicolin. J Protozool 1984;31,306-310.
17. Pfefferkorn ER, Pfefferkorn LC. Arabinosyl nucleosides inhibit Toxoplasma gondii and allow the selection of resistant mutants. J Parasitol 1976;62:993-999
18. Pfefferkorn ER, Pfefferkorn LC. Toxoplasma gondii characterization of a mutant resistant to 5-fluorodeoxyuridine. Exp Parasitol 1977;42:44-55.
19. Pfefferkorn ER, Pfefferkorn LC. The biochemical basis for resistance to adenine arabinoside in a mutant of Toxoplasma gondii. J Parasitol 1978;64:486-492.
20. Pfefferkoni ER, Borotz SE. Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin Antimicrob Agents Chemother 1994;38:31-37
21. Pfefferkorn ER, Eckel ME, McAdams E Toxoplasma gondii in vivo and in vitro studies of a mutant resistant to arprinocid-N-oxide. Exp Parasitol 1988;65:282-289
22. Pfefferkorn ER, Eckel ME, McAdams E. Toxoplasma gondii: the biochemical basis of resistance to emimycin Exp Parasitol 1989; 69:129-139
23. Pfefferkorn ER, Borotz SE, Nothnagel RF. Mutants of Toxoplasma gondii resistant to atovaquone (566C80) or decoquinate. J Parasitol 1992,79,559-564
24. Pfefferkorn ER, Nothnagel RF, Borotz SE. Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug-resistant mutant. Antimicrob Agents Chemother 1992;36:1091-1096.
25. Ricketts AP, Pfefferkorn ER Toxoplasma gondii: susceptibility and development of resistance to anticoccidial drugs in vitro. Antimicrob Agents Chemother 1993,37:2358-2363
26. Schwartzman JD, Pfefferkorn ER. Pyrimidine synthesis by intracellular Toxoplasma gondii. J Parasitol 1981,67.150-158.
27. Schwartzman JD, Pfefferkorn ER. Toxoplasma gondii: purine synthesis and salvage in mutant host cells and parasites Exp Parasitol 1982;53 77-86.
28. Kasper LH, Pfefferkorn ER Hydroxyurea inhibition of growth and DNA synthesis in Toxoplasma gondii: characterization of a resistant mutant. Mol Biochem Parasitol 1982;6.141-150.
29. Lindsay DS, Rippey NS, Toivio-Kinnucan MA, et al Ultrastructural effects of diclazuril against Toxoplasma gondii and investigation of a drug resistant mutant. J Parasitol 1995;81:459-466
30. Chio LC, Queener SF. Identification of highly potent and selective inhibitors of Toxoplasma gondii dihydrofolate reductase Antimicrob Agents Chemother 1993,37:1914-1923.
31. Allegra CJ, Kovacs JA, Drake JC, et al. Potent in vitro and in vivo antitoxoplasma activity of the lipid-soluble antifolate trimetrexate. J Clin Invest 1987;79:478-482.
32. Kovacs JA, Allegra CJ, Swan JC, et al. Potent antipneumocystis and antitoxoplasma activities of piritrexim, a lipid-soluble antifolate. Antimicrob Agents Chemother 1988;32:430-433
33. Grossman PL, Remington JS The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo. Am J Trop Med Hyg 1979,28:445-455.
34. Sheffield HG, Melton ML. Effect of pyrimethamine and sulfadiazine on the fine structure and multiplication of Toxoplasma gondii in cultured cells J Parasitol 1975,61:704-712.
35. Melton ML, Sheffield HG. Activity of the anticoccidial compound, lasalocid, against Toxoplasma gondii in cultured cells J Parasitol 1975,61 713-717.
36. Huber W, Bautz W, Classen M, et al. Pyrimethamine-sulfadiazin-resistente zerebrale toxoplasmosis bei AIDS. Dtsch Med Wochenschr 1995,120:60-64